Form 4 · Filed May 5, 2026, 12:20 AM UTC
LGND/LIGAND PHARMACEUTICALS INC
Reardon Andrew — CLO & Secretary
Pro feature
Read the AI thesis behind every Form 4 — only on Pro and Premium
Free accounts see filings 24 hours late and the thesis is hidden until then. Upgrade to read every Form 4 the moment it hits EDGAR, with a full AI thesis attached (deeper analysis on flagged buys).
Free
FreeBrowse the last 30 days of insider filings. Weekly digest by email.
- · Last 30 days of filings (list view)
- · Conviction score badge on each filing
- · Insider profiles & edge scores
Pro
$15/moAI thesis on every filing + watchlist email alerts.
- · Full AI thesis on every Form 4
- · Full filing history (no 30-day cap)
- · Unlimited ticker watchlists
Premium
$49/moDeep AI theses on flagged setups + SMS alerts + cluster-buy detection.
- · Everything in Pro
- · Deep AI thesis on flagged buys
- · SMS alerts for highest-conviction filings
Transactions
9 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 1, 2026 | M | other | 5,000 | $52 | $261,350 | 46,382 |
| May 1, 2026 | S | sell | 600 | $227 | $136,470 | 45,782 |
| May 1, 2026 | S | sell | 932 | $229 | $213,198 | 44,850 |
| May 1, 2026 | S | sell | 98 | $230 | $22,511 | 44,752 |
| May 1, 2026 | S | sell | 370 | $231 | $85,422 | 44,382 |
| May 1, 2026 | S | sell | 780 | $232 | $180,991 | 43,602 |
| May 1, 2026 | S | sell | 1,420 | $233 | $330,749 | 42,182 |
| May 1, 2026 | S | sell | 800 | $234 | $187,214 | 41,382 |
| May 1, 2026 | M | other | 5,000 | $0 | $0 | 44,444 |
Source: SEC EDGAR raw filing ↗ · Accession 0002001011-26-000046